您要查找的是不是:
- Irbesartan hydrochlorothiazide 厄贝沙坦氢氯噻嗪
- HPLC method for determination of irbesartan ( 1 ) and hydrochlorothiazide ( 2 ) in compound irbesartan tablets was established. 建立同时测定复方厄贝沙坦片中厄贝沙坦和氢氯噻嗪含量的HPLC方法。
- OBJECTIVE To compare the cost-effectiveness between Irbesartan combined with Extended Release Nifedipine or Hydrochlorothiazide in the treatment of the Pure Systolic Hypertension. 目的比较厄贝沙坦与硝苯地平缓释片或氢氯噻嗪片联合治疗单纯性收缩期高血压的经济效果。
- Irbesartan group was similar to EOW group and EOE group. 安博维组疗效与虫草组相似。
- Irbesartan and hydrochlorothiazide 厄贝沙坦/氢氯噻嗪
- Irbesartan and hydrochlorothiazid 厄贝沙坦/氢氯噻嗪
- Irbesartan / hydrochlorothiazide fixed - combination 复方厄贝沙坦
- Captropril Can improve hydrochlorothiazide induces abnomality of glucose metabolism in essential hypertension. 关键词:高血压;开博通;双氢克尿噻;糖耐量;胰岛素
- SBP, DBP and MBP in the combination group decreased slightly than that in the irbesartan group(5 mmHg-10 mmHg, P>0.05). 联合组的SBP及DBP、MBP与厄贝组相比虽无统计学意义(P>0.;05);但有一定的下降趋势(5mmHg~10mmHg)。
- HPLC method for determination of telmisartan and hydrochlorothiazide in compound telmisartancapsules was established. 建立了HPLC法同时测定复方替米沙坦胶囊中替米沙坦和氢氯噻嗪的含量。
- Diabetic nephropathy (Group DN); and diabetic rats treated with irbesartan (Group DNI). 糖尿病肾病组(diabetic nephropathy,DN,Group DN):糖尿病肾病并采用血管紧张素11受体l桔抗剂一厄贝沙坦(i rbesartan,Irb)干预组(Group DNx)。
- Objective To approach the effect of hydrochlorothiazide(HCTZ)on blood uric acid in hypertensive patients. 目的研究原发性高血压患者在使用氢氯噻嗪(HCTZ)降压治疗时,氢氯噻嗪对血尿酸的影响。
- The incidence rate of adverse effect in irbesartan group was 12. 5%, and benazepril group 22.58%. 不良反应发生率国产伊贝沙坦组为12.;5%25,苯那普利组为22
- Results Hydrochlorothiazide was found in 3 formulations, the contents were 0.141%, 0.149% and 2.625% respectively. 结果在6批受试制剂中,3批被检测出非法掺有合成药氢氯噻嗪,其含量质量分数分别为0.;141%25、0
- Aminoguanidine and Irbesartan can play their role of reno-protection via supression of AGEs. 氨基胍和依贝沙坦能通过抑制AGEs引起的上述改变,一定程度上发挥其肾脏保护作用。
- Abstract Micronization of irbesartan (IBS) has been studied using an anti-solvent recrystallization method. 摘要 采用反溶剂重结晶法对疏水性药物依贝沙坦了进行微粉化研究。
- Irbesartan was found to be effective in lowering blood pressure and inhibiting left ventricular hypertrophy. 厄贝沙坦具有明确的降压作用,并有抑制左室肥厚的作用。
- Objective To obseve antihypertensive used irbesartan alone and combined treatment in senile primary hypertension. 目的对厄贝沙坦单用或伍用治疗高血压临床观察。
- A low dose of hydrochlorothiazide &/or the dose of Cozaar should be increased to 100 mg once daily based on blood pressure response. 低剂量氢氯噻嗪和/或剂量科素亚应增加至100毫克,每天一次根据血压反应。
- The adverse reactions in the irbesartan group shown as dizziness, headache, Nausea and dry uh. 厄贝沙坦组主要不良反应为头晕、头痛、恶心、干呵。